Well if a well rested PR has managed to oversee a 97% drop in the SP I don't think it makes much difference. I suspect you will get another opportunity to follow your "strategy" of buying into yet another CR soon.
I hope I'm wrong but I'm far from convinced they have a deal waiting in the wings for the nod from the FDA
Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-50
-
- There are more pages in this discussion • 51 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
23.0¢ |
Change
0.005(2.22%) |
Mkt cap ! $81.36M | |||
| Open | High | Low | Value | Volume |
| 22.5¢ | 24.0¢ | 22.5¢ | $132.4K | 570.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 12 | 174687 | 22.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 23.5¢ | 63529 | 6 |
View Market Depth
| Last trade - 14.10pm 13/11/2024 (20 minute delay) ? |
| PAR (ASX) Chart |